All filters
Slidesets
Where have all the children gone? High HIV prevalence in infants attending nutrition and inpatient wards | Dr. C. Kiyaga
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Outcomes of HIV-exposed infants before and after implementing Option B+ PMTCT guidelines in Kampala, Uganda: a retrospective cohort study | Dr. P. Elyanu
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Impact of tenofovir-containing triple antiretroviral therapy (ART) on bone mineral density in HIV-infected breastfeeding women in sub-Saharan Africa | Dr. L. Stranix
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Option B+: Beyond ART – Experience with Retention and Outcomes | Landon Myer
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
The Challenge of Drug-Resistant TB in Children with HIV | Simon Schaaf, MMed, PhD
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Lung function in HIV-infected South African adolesents on antiretroviral therapy: the Cape Town adolescent antiretroviral cohort | Dr. L. Githinji
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Neuropsychological performance in African HIV children in a multi-site ARV clinical trial is poorer than non-infected children | Dr. M. Boivin
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Pediatric HIV Treatment and Prevention: From Then to Now | Peter Mugyenyi, MB ChB, FRCPI, FRCP
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
New WHO Guidelines on Breastfeeding | Nigel Rollins
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Pediatric Drug Pipeline: New Drugs, New Strategies | Martina Penazzato, MD, DTMH, MSc, PhD
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Testing at Birth – Update from South Africa | Gayle Sherman
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Virological response and resistance among HIV-infected children on first-line antiretroviral therapy without routine virological monitoring | Dr. Andrew Prendergast
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
UNICEF Consultation: Countries Implementation of B+ | Chewe Luo, MD, PhD
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Access to antiretroviral initiation among HIV-infected children aged 0-19 years in the International Epidemiologic Databases to Evaluate AIDS Global Network | Dr. V. Leroy
Presented at:
International Workshop on HIV & Pediatrics 2016
Meeting
Global HIV Clinical Forum 2016
Slidesets
Basic Science of Integrase Inhibitors - Mark Wainberg, MD
Presented at:
Global HIV Clinical Forum 2016
Slidesets
Clinical Case Discussion 1 - Pedro Cahn, MD, PhD
Presented at:
Global HIV Clinical Forum 2016
Slidesets
Resistance Characteristics of Integrase inhibitors - Charles Boucher, MD, PhD
Presented at:
Global HIV Clinical Forum 2016
Slidesets
Integrating Science Into The Clinic: Current and Future Use of Integrase Inhibitors - Anton Pozniak, MD, FRCP
Presented at:
Global HIV Clinical Forum 2016
Slidesets
Only the Best in Botswana - Optimizing the ART Response - Ava Avalos, MD
Presented at:
Global HIV Clinical Forum 2016
Slidesets
Optimizing HIV Therapy in Resource Limited Settings - François Venter, MD, FCP, PhD
Presented at:
Global HIV Clinical Forum 2016
Slidesets
Integrase strand-transfer inhibitors primary resistance in patients with acute/recent HIV infection - Juan Ambrosioni
Presented at:
Global HIV Clinical Forum 2016